I just received this email from the CF Foundation.

Subject: Breaking news: CF drug development
> Date: Fri, 27 Mar 2009 11:27:23 -0400
>
> Dear Friend.
>
> Thank you for all you have done to help advance a cure for cystic fibrosis. I am writing today to share some exciting news with you.
>
> Two promising potential CF drugs took important steps forward this week:
>
> Vertex Pharmaceuticals announced that a potential drug that treats the basic genetic defect in CF moved into phase 2a clinical trials. The drug, known as VX-809, will be tested in CF patient volunteers.
>
> The clinical trials will evaluate the safety and effectiveness of VX-809 in CF patients.
>
> The CF Foundation announced that we will collaborate with Alnara Pharmaceuticals to ensure the development of an important pancreatic enzyme replacement therapy known as liprotamase.
>
> Liprotamase, formerly known as ALTU-135 and Trizytek, was originally discovered and tested by Altus Pharmaceuticals.
>
> Alnara will complete the ongoing studies and see this important product through until it is available to CF patients.
>
> These breakthroughs are two examples of the kind of research that is made possible because of your support.
>
> Without you, this type of work simply would not be funded.
>
> Please consider making a tax-deductible donation today at www.cff.org/GetInvolved/ManyWaysToGive/Donate. Your support will help us continue advancing important CF science.
>
> Thank you for all you are doing to bring us closer to a cure.
>
> Sincerely yours,